| abstract |
The present invention relates to a microorganism for the prevention and treatment of obesity or diabetes mellitus, which is excellent in the viability of the intestine and produces a high efficiency of the polysaccharide in the intestine, more specifically, glucose, sucrose, or fructose, etc. introduced into the intestine are not absorbed into the body. A novel microorganism, a composition containing a pharmaceutically effective amount thereof, and a food composition comprising the same as an active ingredient, which are capable of preventing or treating obesity or diabetes by competitively inhibiting the intestinal absorption of low sugars by converting the same into a polymeric material. will be. |